Form 4: Organogenesis Director Michael Driscoll Acquires Shares and Receives Restricted Stock Units

Director Michael Joseph Driscoll reports acquisition of Organogenesis Holdings Inc. Class A Common Stock and grant of restricted stock units.

Summary

• On February 19, 2025, Michael Joseph Driscoll, a director of Organogenesis Holdings Inc., acquired 49,575 shares of Class A Common Stock at $0.
• Following the transaction, Driscoll directly owns 191,879 shares of Organogenesis Class A Common Stock.
• Driscoll also received a grant of restricted stock units (RSUs) under the Organogenesis 2018 Equity Incentive Plan.
• Each RSU represents the right to receive one share of Organogenesis Class A common stock upon vesting.
• The RSUs vest in full on February 15, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard filing related to stock transactions by a company director. The acquisition of shares and grant of RSUs could be interpreted as a positive sign, but it's not definitively bullish.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This filing indicates activity by a director of Organogenesis Holdings Inc.

Stakeholder Impact

• Shareholders may view the director's stock acquisition as a positive signal.

Key Dates

Keywords

Organogenesis Holdings Inc., Michael Joseph Driscoll, Director, Class A Common Stock, Restricted Stock Units, Equity Incentive Plan, Beneficial Ownership, Form 4